Evidence map›Paper›PMID 33430334›Full record

ReviewJournal of clinical medicine2021

Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience.

Linda D Bosserman, Mary Cianfrocca, Bertram Yuh, Christina Yeon, Helen Chen, Stephen Sentovich, Amy Polverini, Finly Zachariah, Debbie Deaville, Ashley B Lee and 18 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Cancer Immunotherapy-An Overview.Cancer treatment and research · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Linda D BossermanDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0003-3897-4276
Mary CianfroccaDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.
Bertram YuhDepartment of Surgery, City of Hope, Duarte, CA 91010, USA.
Christina YeonDepartment of Medical Oncology and Therapeutics Research, City of Hope, South Pasadena, CA 91030, USA.
Helen ChenDepartment of Radiation Oncology, City of Hope, South Pasadena, CA 91030, USA.
Stephen SentovichDepartment of Surgery, City of Hope, Duarte, CA 91010, USA.
Amy PolveriniDepartment of Surgery, City of Hope, South Pasadena, CA 91030, USA.
Finly ZachariahDepartment Supportive Care Medicine, City of Hope, Duarte, CA 91010, USA.
Debbie DeavilleDepartment of Enterprise Business Intelligence, City of Hope, Duarte, CA 91010, USA.
Ashley B LeeDepartment of Clinical Research Operations, City of Hope, Duarte, CA 91010, USA.
Mina S SedrakDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0002-8379-391X
Elisabeth KingDepartment of Population Sciences in the Division of Clinical Cancer Genomics, City of Hope, Duarte, CA 91010, USA.
Stacy GrayDepartment of Population Sciences in the Division of Clinical Cancer Genomics, City of Hope, Duarte, CA 91010, USA.
Denise MorseDepartment of Quality, Risk and Regulatory Management, City of Hope, Duarte, CA 91010, USA.
Scott GlaserDepartment of Radiation Oncology, City of Hope, Duarte, CA 91010, USA.
Geetika BhattDepartment of Medical Oncology and Therapeutics Research, City of Hope, Lancaster, CA 93534, USA.
Camille AdeimyDepartment of Medical Oncology and Therapeutics Research, City of Hope, Upland, CA 91784, USA.
TingTing TanDepartment of Medical Oncology and Therapeutics Research, City of Hope, Newport Beach, CA 92660, USA.
Joseph ChaoDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.
Arin NamDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0003-1253-6120
Isaac B PazDepartment of Surgery, City of Hope, South Pasadena, CA 91030, USA.
Laura KruperDepartment of Surgery, City of Hope, Duarte, CA 91010, USA.
Poornima RaoDepartment of Surgery, City of Hope, South Pasadena, CA 91030, USA.
Karen SokolovDepartment of Radiation Oncology, City of Hope, Torrance, CA 90503, USA.
Prakash KulkarniDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.
Ravi SalgiaDepartment of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.ORCID 0000-0001-9643-7626
Jonathan YamzonDepartment of Surgery, City of Hope, Duarte, CA 91010, USA.
Deron JohnsonDepartment of Clinical Informatics, City of Hope, Duarte, CA 91010, USA.

Funding

Oncology Research Career Development ProgramK12CA001727 · NCI · CITY OF HOPE NATIONAL MEDICAL CENTER · PI MORTIMER, JOANNE E. · 1992 to 2024
$14.6M
NCI NIH HHS K12 CA001727
6 · The paper itself

Abstract

As the US transitions from volume- to value-based cancer care, many cancer centers and community groups have joined to share resources to deliver measurable, high-quality cancer care and clinical research with the associated high patient satisfaction, provider satisfaction, and practice health at optimal costs that are the hallmarks of value-based care. Multidisciplinary oncology care pathways are essential components of value-based care and their payment metrics. Oncology pathways are evidence-based, standardized but personalizable care plans to guide cancer care. Pathways have been developed and studied for the major medical, surgical, radiation, and supportive oncology disciplines to support decision-making, streamline care, and optimize outcomes. Implementing multidisciplinary oncology pathways can facilitate comprehensive care plans for each cancer patient throughout their cancer journey and across large multisite delivery systems. Outcomes from the delivered pathway-based care can then be evaluated against individual and population benchmarks. The complexity of adoption, implementation, and assessment of multidisciplinary oncology pathways, however, presents many challenges. We review the development and components of value-based cancer care and detail City of Hope's (COH) academic and community-team-based approaches for implementing multidisciplinary pathways. We also describe supportive components with available results towards enterprise-wide value-based care delivery.

Indexed as

cancer care plansEarly Recovery After Surgery (ERAS)integrated cancer careoncology medical homeoncology pathwayssupportive care pathwayssurgical pathwaysteam-based carevalue-based cancer carevalue-based care

Identifiers

PMID33430334
PMCPMC7825796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.